Molecular Templates
Engineering the Next Generation of Therapeutics
26 employees · est. 2001 · Austin, United States
Tolerx, Inc. is the older company (2001 vs 2000); Molecular Templates is the larger of the two.
Side-by-Side Comparison
| Metric | Molecular Templates | Tolerx, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2001 | 2000 older |
| Headquarters | ||
| Headquarters | Austin, United States | Cambridge, United States |
| Employees | ||
| Employees | 26 larger | 9 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Post Ipo Equity | Series Unknown |
| Total Funding | ||
| Total Funding | $372.65M | $145.50M |
| Funding Rounds | ||
| Funding Rounds | 15 | 5 |
| Services | ||
| Services | clinical trials, drug discovery, biopharmaceutical research | Not tracked yet |
| Target Customers | ||
| Target Customers | pharmaceutical companies, healthcare providers, biotechnology investors | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical, Clinical-stage, Cancer Treatment, Biologic Therapeutics, Engineered Toxin Body, ETB Drug Platform, Antibody Drug Conjugates, PD-1/PD-L1, HER2-positive Cancers, Myeloma Treatment, CTLA-4, TIGIT, TROP2, BCMA, Collaboration Agreement | Cancer Treatment, Diabetes Treatment, Autoimmune Disease, Immunotherapy, T Cell Immunotherapy, Drug Development, Clinical Trials, Immune Response Modulation, Antibody Treatment, Pharmaceuticals, Preclinical Candidates, Immune System Regulation, Viral Infections, Immune System Disorders |
| Website | ||
| Website | mtem.com | tolerx.com |
About Molecular Templates
Molecular Templates, headquartered in Austin, Texas, is a cutting-edge biopharmaceutical firm dedicated to innovating the realm of biologic therapeutics. Their focus lies in developing treatments for cancer and other severe illnesses using their proprietary biologic engineered toxin body (ETB) drug...
About Tolerx, Inc.
Tolerx, Inc. is a trailblazer in immunology, with a remarkable array of pioneering drug candidates designed to combat not only type 1 diabetes, but also a range of autoimmune disorders and cancer by restoring balance to immune responses. The company's lineup features otelixizumab, its primary candid...
We will tell you when either one moves
BounceWatch watches Molecular Templates and Tolerx, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Molecular Templates and Tolerx, Inc. — by email.
Frequently Asked Questions
Compare Molecular Templates with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Molecular Templates on 10 Jun 2026, and Tolerx, Inc. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.